Comprehensive genomic insights into lineages, virulence, and antibiotic resistance profiles of Campylobacter jejuni entailing a global One Health scenario Authors: Shamsul Qumar, Mohamad Hamad, Raed AbuOdeh, Ghalia Khoder, Niyaz Ahmed Published: 2026 ABSTRACT AbstractBackgroundCampylobacter species are among the leading causes of bacterial gastroenteritis worldwide, with poultry recognized as a major reservoir for several life-threatening foodborne and zoonotic infections. The overuse and possible misuse of antimicrobials in the livestock sector in different countries of the world have contributed to the emergence of multidrug-resistant Campylobacter jejuni strains with significant public health concerns. To better understand the evolution, host adaptation, and antimicrobial resistance (AMR) of C. jejuni, we performed a global comparative genomic analysis of 1,125 high-quality genomes from human and chicken hosts, including five newly sequenced isolates representing broiler chicken samples.ResultsPangenome analysis of 1,125 C. jejuni genomes identified 4,489 orthologous gene clusters, of which 1,360 constitute the conserved core genome. The findings indicate a weakly open pangenome approaching saturation, suggesting limited gene acquisition. Phylogenomic analysis revealed three major clades with limited geographic clustering, consistent with global dissemination and evolutionary divergence. Human isolates were distributed across all clades, whereas chicken isolates were primarily restricted to clade one. Sequence typing identified 290 STs across 30 clonal complexes, with ST-48 enriched in chickens while ST-50 predominated in humans, reflecting potential host adaptation and epidemiological structuring. All five in-house isolates were multidrug-resistant, producing extended-spectrum β-lactamases (ESBLs) that conferred β-lactam resistance. Additionally, three isolates exhibited resistance to macrolides and tetracycline, further underscoring their broad resistance phenotype. Genome-wide AMR profiling of 1,125 C. jejuni isolates identified 31 well-characterized resistance genes, including those encoding RND and MATE efflux systems, penicillin-binding proteins, and metallo- and serine-beta-lactamase families, underscoring their intrinsic role in the core resistome. The most common resistance mutations were gyrA p.T86I (60.3%) and 23S r2075A>G (4%), conferring resistance to fluoroquinolones and clarithromycin. Analysis of the 1,125 genomes, including the five new isolates, revealed 126 key virulence genes, with cytolethal distending toxin (cdtA, cdtB, and cdtC) and capsule biosynthesis clusters present in over 85% and 93% of the isolates, respectively. ConclusionThese findings provide comprehensive insights into the evolution, transmission dynamics, host adaptation, antimicrobial resistance, and pathogenic potential of C. jejuni. Poultry serves as a critical reservoir contributing to the emergence and dissemination of high-risk, pathogenic, and drug-resistant lineages, underscoring the importance of monitoring and controlling AMR in livestock to protect public health.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13099-026-00848-y.Keywords: C. jejuni, Multidrug-resistance, Antibiotics, Comparative genomics, Chicken, Phylogeny, Pan-genome, Sequence type, Clonal complex, Virulome, Whole-genome sequencing, One-health Background Campylobacter jejuni is a major cause of bacterial gastroenteritis worldwide, contributing to an estimated 96 million cases of diarrheal disease annually [1]. Although self-limiting in most cases, C. jejuni infection can lead to serious post-infectious complications, including Guillain-Barré syndrome, reactive arthritis, and irritable bowel syndrome [2, 3]. The global burden of the disease is disproportionately higher in low- and middle-income countries (LMICs), where poor sanitation, limited surveillance infrastructure, and high antibiotic use contribute to frequent exposure and sustained transmission cycles [4, 5]. In this global context, the situation in LMICs, such as India, is particularly concerning, with the rapidly expanding poultry sector impacting transmission dynamics and contributing to the emergence of antibiotic resistance [6, 7]. A recent study highlights the substantial burden of C. jejuni, wherein > 80% of the isolates from diarrheal patients and poultry were found to be resistant to at least one antibiotic, reflecting its clinical importance and widespread prevalence in avian reservoirs [6, 8]. Poultry is widely recognized as the primary reservoir of C. jejuni, with chickens serving as a major source of human infection through consumption of contaminated meat and cross-contamination in domestic kitchens [9, 10]. Colonization of the chicken intestinal tract by C. jejuni is typically asymptomatic but can occur at high levels, with intestinal bacterial loads reported to reach 10⁶−10⁹ CFU/g of faeces [11]. This makes poultry production environments a critical ecological niche for the amplification and transmission of pathogenic and antibiotic-resistant C. jejuni strains. In India, poultry farming is a rapidly expanding sector, characterized by high animal densities, widespread prophylactic and metaphylactic antibiotic use, and variable safety practices [12, 13]. The global burden of infectious diseases is high, and the disproportionate use of antimicrobial agents to combat them has already resulted in the emergence of multidrug-resistant (MDR) organisms. The high prevalence of MDR organisms in livestock and livestock-derived products has been strongly influenced by inappropriate and irrational use of antimicrobials in veterinary practices and animal husbandry, particularly as prophylactic agents and growth promoters [14]. These antimicrobial-resistant (AMR) bacteria significantly compromise treatment efficacy, leading to increased morbidity and mortality in both livestock and humans [15]. The escalating challenge of AMR is exacerbated in LMICs, driven by high population density, inadequate sanitation, and somewhat lax antibiotic regulations [16]. Additionally, only a few novel antimicrobial agents are currently in the global pipeline [17]. Therefore, AMR is the greatest threat to public health. The dissemination of resistant bacteria and their associated genes across human and animal populations positions AMR as a contentious One Health challenge [18–20]. Amid the continued rise of AMR, characterizing organisms is imperative for generating robust, reliable epidemiological surveillance data. Chicken, a major source of dietary protein worldwide, is experiencing rapid consumption growth, making it one of the fastest-growing food markets globally. To satisfy the high demand for chicken meat, poultry industries routinely use a range of antibiotics indiscriminately to promote faster growth [21]. Epidemiological evidence consistently implicates that the majority of foodborne bacterial infections caused by Campylobacter, Escherichia coli [22], non-typhoid Salmonella [23] and other pathogens are primarily transmitted via animal-derived foods. Furthermore, C. jejuni has been reported on poultry carcasses, possibly due to contamination during the poultry rearing and slaughtering process [24]. The emergence of MDR C. jejuni isolates, particularly those resistant to fluoroquinolones, macrolides, and third-generation cephalosporins, poses a significant public health challenge [25–27]. Despite India’s high population and substantial chicken consumption, comprehensive genome-based studies and AMR profiling of C. jejuni from retail poultry remain scarce, limiting insights into its molecular epidemiology. Moreover, the global prevalence of C. jejuni in human and poultry sources underscores the critical need for comprehensive genome-based studies to unravel its transmission dynamics, niche adaptation, AMR patterns, and global molecular epidemiology. With advances in next-generation sequencing (NGS) technologies and improved access to global supply chains, many low- and middle-income countries are now better positioned to contribute to global surveillance initiatives. Here, our work highlights the importance of a One Health perspective by exploring transmission dynamics and pathogenic potential of C. jejuni across humans and poultry, particularly chickens, on a global scale [28–30]. Within the One Health framework, considerable progress has been made in understanding the clinical and veterinary dimensions of C. jejuni. The veterinary perspective has been central to identifying infection reservoirs in livestock and poultry, assessing zoonotic risks, and informing strategies for disease prevention and control. Veterinary research also provides crucial insights into pathogen diversity and host interactions, making it an essential component of a comprehensive One Health strategy. In this context, our analysis of 1,125 open-source C. jejuni genomes, including five newly sequenced isolates, offers valuable insights that reinforce the veterinary and clinical perspectives and advance understanding of this pathogen at both local and global scales. Materials and methods Microbiological and sequencing methods for C. jejuni isolation and characterization Gastrointestinal tract samples from broiler chickens were obtained from commercial poultry abattoirs in 2015, collected in sterile Falcon tubes, and processed within 3–4 hours, following the protocol described by Qumar et al. [31]. The caeca were aseptically excised, washed once with 1X PBS, and their contents discarded. The tissues were cut into small pieces and homogenized in 5 mL of Brain Heart Infusion (BHI) broth (BD Difco, USA) using a sterile tissue homogenizer. A 100 µL sample of the tissue homogenates was diluted in 300 µL of BHI, and 100 µL of this diluted suspension was placed onto BHI agar (BD Difco, USA) plates supplemented with 10% horse serum, amphotericin B (3 mg/L), cefoperazone (32 mg/L), and vancomycin (10 mg/L) using a modified filter technique [32]. Briefly, a 0.65 µm sterile cellulose acetate membrane filter was placed on the agar surface, and 100 µL of the diluted homogenate was applied to it, selectively enriching for motile Campylobacter species in a complex background microbiota. The agar plates were incubated at 37 °C for 1–2 hours under microaerobic conditions (90% N2, 5% O2, and 5% CO2). Following filtration, membrane filters were removed with sterile tweezers, and the filtrate was streaked onto the agar with a sterile loop. Plates were incubated for an additional 3–4 days under the same conditions to allow the bacterial colonies to grow. The colony PCR assay for the C. jejuni 16S rRNA gene, using specific primers (forward 5’-TTAAGCGATGCAGGAATGCC-3’ and reverse 5’-TGACAAAATGCTGAGCTTACAAG 3’), was performed for species confirmation. PCR products were resolved on a 1.2% agarose gel and visualized using a gel documentation system (Major Science). The antimicrobial susceptibility of all isolates was tested using the Kirby-Bauer disk diffusion method using twelve antibiotics discs (HiMedia, Mumbai, India): doxycycline hydrochloride (30 µg), oxytetracycline (30 µg), chlortetracycline (30 µg), nalidixic acid (30 µg), ciprofloxacin (5 µg), enrofloxacin (5 µg), neomycin (10 µg), cefotaxime (30 µg), clarithromycin (15 µg), co-trimoxazole (25 µg), chloramphenicol (30 µg), and colistin (10 µg). Bacterial suspensions were standardized to 0.5 McFarland in BHI broth (BD Difco, USA) and evenly spread on BHI agar (BD Difco, USA) plates using a sterile cotton swab. Antibiotic discs were placed on the agar surface using sterile tweezers, and plates were incubated at 37 °C for 3–4 days under microaerobic conditions, as previously described. Production of extended-spectrum beta-lactamases (ESBLs) was tested for all isolates using the double disc synergy test [39, 40]. Antibiotic susceptibility results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) recommendations (2009) [41]. Genomic DNA was extracted using the Qiagen DNeasy Blood and Tissue kit (Qiagen, Germany). Yield and quality were assessed using a NanoDrop spectrophotometer (Thermo Scientific). Whole-genome sequencing (WGS) of all isolates was carried out using an Illumina MiSeq sequencer, generating about 0.5–1.2 million paired-end reads of 300 bp, with an insert size of 400 to 500 bp. Paired-end reads were filtered and trimmed using the NGS QC Toolkit [33] and the FastX tool [http://hannonlab.cshl.edu/fastx_toolkit/], respectively. High-quality reads were assembled de novo using SPAdes genome assembler v3.0.0 [34]. Gene prediction and functional annotation of the draft genomes were performed using PROKKA (v1.14.6) [35]. Genome statistics for these strains were determined using QUAST v5.1.0 [36]. The numbers of tRNA and rRNA genes were identified using tRNAscan-SE and RNAmmer [37], respectively. Assembled genome sequences of all five C. jejuni isolates have been submitted to NCBI. The genome sequences are available in the NCBI nucleotide database by searching for the accessions JBRESE000000000, JBRFHW000000000, JBRZMI000000000, JBRZMJ000000000, and JBRZMK000000000 for C. jejuni isolates 2H, 4H, 5H, 6H, and 7H, respectively. Prospecting, acquisition, and curation of global genome data On May 5, 2025, C. jejuni genome assemblies, both complete and draft, were retrieved from the NCBI assembly database using the NCBI Datasets Command Line Interface (CLI). Human- and chicken-derived C. jejuni isolates were identified using Biosample metadata. To ensure high-quality genomic data, genomes were filtered based on the following criteria: (i) no more than 200 scaffolds or contigs, (ii) GC content of 30%−31%, (iii) genome size of 1.6–1.9 Mbp, and (iv) N50 value greater than 50,000 bp. Quality assessment was further refined using CheckM v.1.2.4 [38] (default settings) to evaluate genome completeness and contamination, retaining genomes with ≥ 99% completeness and ≤ 1% contamination. Genome statistics and quality were verified using QUAST v5.1.0 [36]. The NCBI Datasets CLI enabled efficient retrieval of both genome assemblies and their corresponding BioSample metadata, including XML files. Whole genome-based screening of AMR determinants and resistance-conferring point mutations Comprehensive screening for AMR genes was performed across 1,125 C. jejuni genomes, including 1,120 open-source and five in-house isolates. AMR gene screening was conducted using ABRicate (v1.0.1) (https://github.com/tseemann/abricate) against the Comprehensive Antibiotic Resistance Database (CARD; updated on 6 March 2025), applying an identity and query coverage thresholds of 80%. Chromosomal point mutations associated with AMR were identified using the standalone PointFinder tool (v4.1.0) with the C. jejuni species-specific database, using the same identity and coverage thresholds. Generation of pangenome data and construction of phylogenetic relationships Following genome annotation, a pan-genome analysis was performed using Panaroo v1.5.1 [42]. Core genes were defined as those present in at least 99% of genomes, whereas accessory genes were present in at least 1% but fewer than 95% of genomes. Panaroo was run in strict mode, and gene clusters were aligned using the MAFFT aligner implemented within Panaroo. The concatenated core-genome alignment generated by Panaroo was used to construct a maximum-likelihood phylogenetic tree using IQ-TREE (v1.6.12) [43], under the general time-reversible model with a gamma distribution of rate heterogeneity (GTR + G), with 1,000 ultrafast bootstrap replicates. The resulting phylogenetic output tree was visualized using iTOL (Interactive Tree of Life v7) [44]. To evaluate whether the C. jejuni pan-genome is open or closed, Heaps’ law was applied to model the relationship between the number of analyzed genomes and the total number of genes, using 1,000 iterations. Heaps’ law is formulated as n = κNβ, where n is the number of gene families observed after sampling N genomes, κ is a scaling constant, and β reflects the openness of the pangenome. The pan-genome expansion parameter (β) was estimated using nonlinear least-squares regression on log-transformed data, where a β value > 0 indicates an open pan-genome, while β ≈ 0 suggests a closed genome, providing insights into genomic diversity and gene acquisition potential among the analyzed strains [45]. Sampling bias was minimized by permutation-based averaging. Core genome size was calculated as the number of gene families present in all genomes for each permutation, averaged across permutations. The number of novel genes contributed by each additional genome was derived as the first derivative of the fitted Heaps’ law model. Graphs were generated using Matplotlib (v3.10.0). Furthermore, the core and specific coding sequences of C. jejuni isolates were annotated using the EggNOG v5.0 database (http://eggnog5.embl.de/#/app/home) [46]. For functional annotation, eggNOG-mapper v2 [47] was utilized with DIAMOND and default settings. The parameters included an e-value threshold of 0.001, a minimum bit score of 60, and a minimum query and subject coverage of 20%. The analysis was carried out using an automatic taxonomic scope and restricted to non-electronic Gene Ontology (GO) evidence to enhance annotation quality. Whole genome-based virulome and mobilome profiling Virulence factor prediction across the 1,120 open-source and five in-house genomes was performed using ABRicate (v1.0.1) (https://github.com/tseemann/abricate) with an identity and query coverage of 80% against the Virulence Factor Database (VFDB, updated on 6 March 2025) [48]. Mobile genetic elements, including integrons, replicons, and transposon regions, were identified using the standalone version of BacAnt v.3.3.1 with default parameters [49]. Multi-locus sequence typing (MLST) and clonal complex (CC) analysis C. jejuni isolates from human and poultry sources were genotyped using multi-locus sequence typing (MLST) (https://github.com/tseemann/mlst), employing the scheme of Dingle et al. [50]. All 1,125 genomes were assigned sequence types (STs) based on allelic profiles of seven housekeeping genes (aspA, uncA, glnA, gltA, glyA, pgm, tkt). Allelic profiles were queried against the PubMLST C. jejuni database (https://pubmlst.org/campylobacter) to assign clonal complexes (CCs) based on predefined criteria: STs sharing ≥ 6 of 7 alleles with a founder genotype were grouped into the same CC. This approach enabled assessment of population structure and genetic diversity across human- and poultry-associated C. jejuni isolates. Statistical analysis Statistical analyses were performed to assess associations between genomic features (AMR genes, virulence factors, sequence types (STs), and host source (chicken vs. human) in C. jejuni. Contingency tables were constructed based on presence/absence or categorical data. The Chi-square (χ²) test was used for comparisons with sufficient expected counts, while Fisher’s exact test was applied when expected frequencies were < 5. For sequence type analysis, only predominant epidemiologically relevant STs were included in inferential testing to avoid sparse contingency structures associated with low-frequency lineages. A p-value of < 0.05 was considered statistically significant. All analyses were conducted in Python (v3.12.2) using the SciPy library (v1.15.2). Results Genome report of 5 in-house C. jejuni genomes Five C. jejuni strains were isolated from broiler chickens obtained from different retail wet markets in Hyderabad, India. The chickens were sourced from farms that employed formula feed and routinely used antibiotics. Initial characterization by Gram's staining revealed small, curved Gram-negative rods, consistent with C. jejuni morphology. Species confirmation was subsequently performed by PCR targeting the C. jejuni-specific 16S rRNA gene. All five in-house C. jejuni isolates from broiler chickens exhibited MDR. All isolates were fully resistant to fluoroquinolones (ciprofloxacin, nalidixic acid, enrofloxacin), sulfonamides (co-trimoxazole), and cephalosporins (cefotaxime). In addition, three isolates were resistant to macrolides (clarithromycin) and tetracyclines (oxytetracycline, chlortetracycline, and doxycycline hydrochloride). All isolates were susceptible to chloramphenicol and colistin but tested positive for ESBL production, exhibiting resistance to β-lactams despite the presence of clavulanic acid, a β-lactamase inhibitor (Table 1). Table 1Antimicrobial resistance profile of five C. jejuni isolates from broiler chickensResistance phenotypeAntibiotic susceptibility profile of broiler chickenisolates (in-house) Antimicrobial class Specific traits2H 4H5H6H7HQuinolone/fluoroquinoloneCiprofloxacinRRRRRNalidixic acidRRRRREnrofloxacinRRRRRSulfonamide/trimethoprimCo-trimoxazoleRRRRRCephalosporinCefotaximeRRRRRMacrolideClarithromycinSRRRSAminoglycosidesNeomycinSSSRSPhenicolsChloramphenicolSSSSSTetracyclinesOxytetracyclineSRRRSChlortetracyclineSRRRSDoxycyclinehydrochlorideSRRRSMiscellaneousColistinSSSSSESBL phenotypeRRRRRClavulanic acidRRRRR Multidrug resistance MDRMDRMDRMDRMDR Antimicrobial resistance profile of five C. jejuni isolates from broiler chickens Quinolone/ fluoroquinolone Sulfonamide/ trimethoprim Doxycycline hydrochloride Genome sequencing and assembly of the in-house C. jejuni isolates revealed an average genome size of 1.7 Mbp, a GC content of 30.3%, and an average N50 value of 133,760 bp. The genome coverage of sequenced isolates ranged from 142x to 182x. The coding percentage for all isolates was approximately 93.04%, encoding an average of 1672 protein-coding sequences. All isolates contained an average of 3 rRNA and 32 tRNA genes, except the 4H C. jejuni isolate, which harbored 4 rRNA and 38 tRNA genes. Detailed genomic features of the five newly sequenced C. jejuni isolates are summarized in Table 2. Table 2Geographical origin of the isolates and assembly statistics of their genomes (Accession IDs, GC content, total genome length, number of contigs, N50 value, rRNA and tRNA count and genome coverage)Isolates IDCollection date (yr-mo-day)Geographical locationIsolation sourceGenome accessionTotal lengthGC (%)Number of contigsN50 value (bp)Genome Coverage (x)No. of tRNANumber of rRNA 2H2015-05-03India: HyderabadcecumJBRESE0000000001,722,22630.3628123,553168323 4H2015-05-08India: HyderabadcecumJBRFHW0000000001,753,39230.2540114,378156384 5H2015-05-24India: HyderabadcecumJBRZMI0000000001,793,33630.2559132,061142323 6H2015-05-30India: HyderabadcecumJBRZMJ0000000001,725,89230.256156,723165323 7H2015-06-09India: HyderabadcecumJBRZMK0000000001,709,09130.4332142,086182323 Geographical origin of the isolates and assembly statistics of their genomes (Accession IDs, GC content, total genome length, number of contigs, N50 value, rRNA and tRNA count and genome coverage) Characteristics of curated, global C. jejuni genome collection for comparative analysis In addition to the five C. jejuni in-house isolates, 1,120 publicly available human- and chicken-derived genomes from diverse geographical regions and climates were retrieved, resulting in a comprehensive dataset of 1,125 C. jejuni genomes. Of these, 13.3% (n = 149) represented complete assemblies, while 86.7% (n = 971) were draft genomes, comprising 1,029 human and 91 chicken-derived C. jejuni genomes. The selected genomes contained no more than 200 contigs, with an average N50 of 206,000 bp, an average genome size of 1.69 Mbp, and an average GC content of 30.4% (Fig. S1). Metadata revealed broad geographical representation, with the 1,125 isolates originating from 28 countries and 22 distinct sample sources across human and chicken hosts. The dataset was composed mainly of genomes from the United Kingdom (28.4%, n = 320), followed by Peru (10.04%, n = 113), China (9.77%, n = 110), the United States (8.26%, n = 93), India (8.0%, n = 90), Finland (6.84%, n = 77), and Switzerland (5.42%, n = 61), with all remaining countries contributing fewer than 5% of genomes. Among human-derived samples, feces/stool, clinical specimens, rectal/anal swabs, and blood were the predominant sources, whereas cloacal swabs, cecal contents, and intestinal contents were most common in chicken samples. This diversity underscores the dataset’s extensive geographical scope and host relevance (Tables S1 and S2). Global C. jejuni pangenome and its phylogenetic significance Pan-genome analysis using Panaroo identified 4,489 orthologous gene clusters across both in-house and publicly available C. jejuni genomes. Of these, 1,360 core genes were present in at least 99% of isolates, while 53 were classified as soft-core genes (present in 95–99% of isolates). Additionally, 524 shell genes (present in 15–95% of isolates) and 2,552 cloud genes (found in fewer than 15% of isolates) were identified. The core genome accounted for approximately 30% of the total pangenome, representing the conserved genetic backbone shared among C. jejuni strains. In contrast, cloud genes constituted approximately 57% of the pangenome, reflecting the presence of rare or strain-specific gene families that contribute to genetic variability within the species. To assess the openness of the pangenome, the cumulative number of gene families was modeled using Heaps’ law (Fig. 1). The fitted model produced a scaling exponent of β = 0.11 ± 0.000, indicating a weakly open pangenome approaching saturation as additional genomes are incorporated. Analysis of the early portion of the dataset (first 200 genomes) yielded a slightly higher exponent (β = 0.15 ± 0.001), suggesting that the rate of gene discovery declines as sampling increases. The decreasing exponent between early and full datasets reflects progressive saturation of gene diversity within the population (Fig. 1a). Using a 99% presence threshold, the core genome stabilized at ~ 1,360 genes, closely matching the asymptotic estimate from exponential decay modeling (~ 1,362 genes) (Fig. 1b). This strong concordance indicates that the core genome has largely converged and is unlikely to expand with additional genomes, reflecting a conserved set of genes essential for fundamental cellular functions. Consistent with this pattern, the rate of novel gene acquisition per genome decreased from 2.21 new genes per genome at 200 genomes to 0.48 per genome at 1,125 genomes, suggesting substantial saturation of the gene repertoire (Fig. 1c). This declining trend indicates that the majority of gene diversity has already been captured in the current dataset, although a small number of previously unseen genes can still be identified with additional sampling. Pangenome dynamics across 1,125 genomes (a) Pangenome expansion curve showing the cumulative number of gene families as genomes are sequentially added. The point curves (blue and green) represent observed pangenome sizes obtained from random genome permutations for the early dataset (first 200 genomes) and the full dataset (1,125 genomes), while the fitted curve (red) corresponds to Heaps’ law models. The scaling exponent (β = 0.114) indicates an open but slowly expanding pangenome.(b) Core genome decay showing the number of genes present in at least 99% of genomes as additional genomes are included. Points represent observed values, and the dashed line shows the exponential decay model, which predicts an asymptotic core genome size of approximately 1,362 genes. (c) Predicted number of newly discovered gene families per additional genome derived from the Heaps’ law model, demonstrating a decline in gene discovery rate from early sampling to larger genome sets. The phylogenetic tree, constructed from core gene alignments, revealed three major clades. C. jejuni isolates of human origin were distributed across all three clades, highlighting clear evolutionary divergence, whereas chicken isolates, including the in-house chicken isolates, were restricted to clade 1, with a small proportion appearing in clades 2 and 3 (Fig. 2). The predominance of chicken isolates in clade 1 suggests possible host-specific adaptation or restricted genetic diversity within poultry-associated lineages. Overall, these findings suggest host-associated phylogenetic patterns, with chicken isolates restricted to a single lineage, whereas human isolates exhibited broader phylogenetic diversity, consistent with multiple sources of infection and complex transmission dynamics. The occurrence of human isolates within clades dominated by chicken strains further supports poultry as a key reservoir for human infection. Of 1,360 core gene clusters, 1,253 could be assigned into various functional categories according to the COG database (Fig. 3a). The COG functional classification revealed a high proportion of genes belonging to J, C, E, M, and P functional classes. Class J represents genes having functions related to translation, ribosomal structure and biogenesis, while classes C, E, M, and P contain genes involved in energy production & conversion, amino acid transport/metabolism, cell wall/membrane/envelope biogenesis, and inorganic ion transport and metabolism, respectively. The presence of core genome-encoded genes in C. jejuni, including RND (Resistance-Nodulation-Division) efflux systems, MATE (Multidrug And Toxic Compound Extrusion) efflux family proteins, outer membrane lipoproteins, beta-lactamase superfamily domains, penicillin-binding proteins (PBPs), and ABC transporters, highlights the bacterium’s intrinsic mechanisms for drug resistance and environmental adaptability [51]. The MATE efflux family represents a conserved transporter system that expels structurally diverse compounds, including antibiotics and toxic metabolites, across the inner membrane using the proton-motive force, thereby contributing to multidrug resistance and survival under stress conditions [52, 53]. The RND-type efflux systems, such as CmeABC, work in coordination with outer membrane lipoproteins to extrude antimicrobials directly from the cell, thereby enhancing resistance to bile salts and antibiotics, particularly fluoroquinolones and tetracyclines [54, 55]. Beta-lactamase-related genes, including metallo-beta-lactamase and other beta-lactamase superfamily domains, indicate a conserved potential to hydrolyze beta-lactam antibiotics, whereas PBPs are essential for cell wall biosynthesis and are targets for these antibiotics [56–58]. ABC transporter ATP-binding proteins and permeases further support nutrient acquisition and efflux of harmful compounds. Collectively, these core genome-encoded genes suggest that C. jejuni harbors a conserved genetic toolkit for multidrug resistance, efflux-mediated defense, and cell wall maintenance, likely contributing to its persistence in both host and environmental niches. Core genome-based phylogenetic tree depicting the genetic relationships among human and chicken C. jejuni isolates, illustrating their evolutionary relatedness, lineage distribution, and potential host-associated clustering across the major clades. Functional classification of C. jejuni genes. (a) COG functional distribution of the 1,253 core genes shared across all analyzed genomes; bars represent the number of genes assigned to each COG category. (b) COG functional distribution of the 459 strain-specific genes identified in the five in-house C. jejuni isolates, with the x-axis denoting the number of genes and the y-axis the functional categories. C. jejuni-specific gene content analysis identified 459 species-specific genes across all 1,125 isolates. Of these, ~ 20% (89) were classified as hypothetical/unknown, whereas the remaining 37% (171) were grouped into COG categories, with the majority assigned to replication, recombination & repair, cell wall/membrane/envelope biogenesis, defense mechanisms, inorganic ion transport & metabolism, transcription, and multiple classes. A high proportion of genes (43%) were unassigned by COG (Fig. 3b). COG classification of genes across 1,125 genomes revealed strong enrichment of phage-associated genes, conjugation machinery, and CRISPR-Cas components. The concurrent presence of mobile genetic elements and defense systems highlights an evolutionary dynamic that favors both gene acquisition and protection [59]. High representation of domains of unknown function (DUFs) in prophage-rich regions indicates unexplored genetic diversity that may contribute to environmental adaptation or pathogenicity. Whole genome-based resistome profiling of C. jejuni The genome dataset (n = 1,125) was screened for AMR determinants, revealing a complex resistome landscape shaped by diverse evolutionary trajectories and selective pressures within the C. jejuni population. Across this dataset, 31 distinct AMR determinants were identified, conferring resistance to multiple antibiotic classes, including β-lactams, tetracyclines, aminoglycosides, macrolides, lincosamides, and phenicols, as well as genes encoding multidrug efflux systems (Fig. 4). The cmeABC multidrug efflux operon and its regulator cmeR were almost universally present, with cmeA, cmeC, and cmeR detected in over 99.8% of genomes, while cmeB was present in 86.7%. All 96 chicken-derived isolates, including the five in-house strains, harbored these genes, indicating strong conservation of this resistance mechanism in poultry-associated lineages, whereas prevalence among human-derived isolates remained consistently above 93%. The tetracycline resistance gene tetO was detected in 42.6% of genomes but showed a significantly higher prevalence in chicken isolates (70.83%) than in human-derived strains (36.8%) (χ² = 40.99, p < 0.001), with all five in-house poultry isolates carrying tetO, reflecting the impact of tetracycline use in livestock. Heatmap depicting the distribution and prevalence of antimicrobial resistance (AMR) genes across 1,125 C. jejuni genomes from human and chicken sources worldwide. The figure delineates the diversity and frequency of AMR determinants in the overall dataset and separately for human and chicken isolates, providing a comprehensive overview of the global C. jejuni resistome. β-lactam resistance was primarily mediated by OXA-type β-lactamases, with OXA-450 the most prevalent variant, identified in 63.47% of genomes overall and occurring more frequently in poultry-derived isolates (68.75%) than in human-derived isolates (58.60%); however, this difference was not statistically significant (χ² = 3.34, p = 0.067). Several other OXA variants, including OXA-447, OXA-61, OXA-184, and OXA-185, were detected at lower frequencies (3–5%), while rare variants, such as OXA-446, OXA-449, OXA-451, OXA-452, OXA-453, OXA-465, OXA-185, OXA-466, and OXA-448, appeared in less than 1% of the genomes. The identification of TEM-116, a class A β-lactamase, in a single in-house chicken isolate, and its absence from the remaining 1,124 global C. jejuni genomes, represents a novel and noteworthy finding. Aminoglycoside resistance genes were detected at low to moderate frequencies, with APH(3’)-IIIa the most prevalent, present in 5.6% of isolates overall and occurring more frequently in chicken-derived isolates (14.58%) than in human-derived isolates (3.98%), a difference that was statistically significant (χ² = 18.99, p < 0.001). Other aminoglycoside resistance genes, including APH(2’’)-If, SAT-4, and aad(6), were detected in fewer than 3% of isolates, while genes such as ANT(6)-Ia, APH(2’’)-IIa, and AAC(6’)-Im were identified only in single genomes. A small subset of low-frequency resistance genes was shared between the two host groups, including tet(L), ErmB, lnuC, and Campylobacter_coli_chloramphenicol_acetyltransferase, suggesting possible horizontal gene transfer or shared exposure to antimicrobials. The higher prevalence of several resistance determinants in poultry-derived genomes, particularly tetO, and APH(3’)-IIIa, is supported by statistical analysis, whereas differences observed for OXA-450 were not statistically significant, suggesting that antimicrobial use in animal agriculture may be a key selective force driving the acquisition and persistence of these genes. Overall, this analysis highlights the widespread and diverse nature of AMR in C. jejuni, with host-associated variation and rare gene occurrences suggesting ongoing horizontal gene exchange and adaptation under selective pressure in both human and animal-associated reservoirs. Genome-wide analysis of resistance-conferring point mutations in C. jejuni We performed a genomic analysis of 1,125 C. jejuni isolates to map key mutations in the 23S rRNA, gyrA, and rpsL genes that confer resistance to macrolides, fluoroquinolones, and aminoglycosides, respectively, to elucidate prevalent resistance mechanisms, host-specific variations, and potential zoonotic or environmental pathways for the dissemination of resistant strains. Fluoroquinolone resistance was the most prevalent among the isolates (~ 63%) and was primarily mediated by mutations in the quinolone resistance-determining region (QRDR) of the gyrA gene. The p.T86I (ACA → ATA) mutation was the most frequent, detected in 54.8% (616/1,125) of human isolates and 5.5% (62/1,125) of chicken isolates, representing 60.3% (678/1,125) of all isolates (Fig. 5). This mutation is a stable, high-frequency marker of fluoroquinolone resistance in C. jejuni, with no significant host-specific differences observed. Additional gyrA mutations, including p.D90N (n = 15), p.P104S (n = 11), p.T86A (n = 1), and p.T86K (n = 1), were identified exclusively in human-derived isolates; all are known to reduce quinolone binding to DNA gyrase, thereby diminishing antibiotic efficacy and potentially contributing to treatment failure. The stacked bar graph illustrates the prevalence of gene-specific mutations across 1,125 C. jejuni genomes from human and chicken sources worldwide. The figure highlights the diversity and distribution of mutations across human and chicken isolates, offering a comprehensive view of the global C. jejuni mutational landscape. Macrolide resistance in Campylobacter was associated with point mutations in the 23S rRNA gene, detected in 6.5% of isolates, predominantly at positions 2074 and 2075. The most frequent mutation was 23S r2075A > G (n = 45), followed by substitutions at position 2074: A > T (n = 15), A > C (n = 10), and A > G (n = 3) (Fig. 5). These alterations affect the peptidyl transferase region of the 50S ribosomal subunit, thereby reducing macrolide binding affinity. Notably, the distribution of these mutations was host-specific: in human isolates, 23S r2075A > G was present in 44 genomes, while 2074 A > T, 2074 A > C, and 2074 A > G were observed in 15, 10, and 3 genomes, respectively. In contrast, chicken isolates exhibited only a single instance of 23S r2075A > G, with no other mutations detected. Aminoglycoside resistance, specifically to streptomycin, was identified by detecting the p.K43R mutation (AAA → AGA) in the rpsL gene. This substitution alters the S12 protein of the 30S ribosomal subunit, interfering with streptomycin binding. The mutation was observed in four isolates (two human-derived and two chicken-derived), indicating a relatively low but measurable prevalence of resistance in the examined C. jejuni population. Virulome diversity and niche-adapted traits in C. jejuni A comprehensive virulome analysis of 1,125 C. jejuni genomes, comprising 1,029 human-derived isolates and 96 chicken-derived isolates, revealed a rich repertoire of virulence-associated genes, with several factors showing near-universal distribution (Fig. 6). A total of 126 distinct virulence factors were identified across all isolates, predominantly associated with motility and flagella, adhesion and invasion, chemotaxis, capsule and lipooligosaccharide (LOS) biosynthesis, and cytolethal distending toxin production. Heatmap depicting the presence and distribution of virulence factors across a global collection of human and chicken C. jejuni isolates, categorized by their mechanism of action, highlighting patterns of conservation, host association, and potential functional significance in pathogenicity. Core virulence factors, particularly those involved in motility and chemotaxis, were highly conserved across isolates. Genes associated with flagellar assembly, motility regulation, and chemotactic signalling were detected in over 93% of genomes, with 100% conservation in chicken-derived isolates. The cadF and pebA genes, responsible for fibronectin binding and epithelial cell adhesion, were also detected in 93.4% of genomes overall, with 100% prevalence in chicken isolates. The capsule biosynthesis gene cluster (kps operon) was consistently identified in over 93% of genomes, underscoring its key role in immune evasion and host adaptation. While prevalence was high in both groups, chicken isolates showed slightly higher uniformity (≥ 99%) than human isolates (≥ 88–93%) (Fig. 6). Genes involved in LOS biosynthesis, such as waaC, waaF, waaV, htrB, gmhA, gmhB, hldD, and hldE, were universally present in all chicken-derived isolates and highly prevalent in human isolates (> 93%), highlighting the importance of LOS in pathogenesis, especially in immune modulation and serum resistance. Interestingly, cytolethal distending toxin (CDT) genes (cdtA, cdtB, and cdtC), which encode a genotoxic DNase complex, showed differential distribution across hosts. The cdtC gene was highly prevalent in chicken-derived isolates and showed a statistically significant association with host source (χ2 = 6.79, p = 0.009). Similarly, the cdtA and cdtB genes also showed significant differences between chicken- and human-derived isolates (χ2 = 9.22, p = 0.002; χ2 = 11.17, p = 0.00083, respectively). Although all three subunits were widely distributed across both hosts, their differential prevalence suggests variation in the genetic maintenance of this virulence determinant. The presence of the full CDT operon in most genomes indicates a widespread potential for genotoxic activity in C. jejuni, which may contribute to host-cell DNA damage and cell-cycle arrest and has been implicated in carcinogenic outcomes [60]. Glycosylation-associated genes, including pseA-pseI and ptmA/ptmB, which are involved in flagellin modification and immune evasion, were highly conserved, detected in > 89% of human-derived and > 95% of chicken-derived isolates. However, pseE (maf5) showed a strong and statistically significant association with host source (χ2 = 17.63, p = 2.7 × 10− 5), while pseD also demonstrated a significant but weaker association (χ2 = 5.50, p = 0.019). In contrast to the highly conserved glycosylation backbone genes, the variability observed in pseE and pseD suggests potential lineage-specific diversification and host-associated modulation of flagellar glycosylation systems. Accessory and hypervariable virulence genes showed substantial diversity across the dataset. The flagellin-encoding genes flaA and flaB were identified in 28.0% and 24.9% of genomes, respectively, with a modestly higher prevalence in chicken-derived isolates (36.5% and 35.4%). However, only flaB showed a statistically significant association with host source (χ2 = 5.26, p = 0.022), whereas flaA did not differ significantly between host groups (χ = 3.05, p = 0.081), indicating gene-specific variation in flagellar composition. The sialylation and LOS phase variation-associated genes (Guillain-Barré syndrome (GBS)-associated virulence factors) (wlaN, cstIII, neuB1, neuC1, and neuA1) were detected in 16–19% of genomes, with comparable prevalence in human- and chicken-derived isolates. A limited set of type IV secretion system (T4SS) genes, including virB4-virB11 and virD4, was identified in only 1.3% of total genomes and was exclusively found among human isolates, suggesting possible acquisition via horizontal gene transfer and a restricted distribution within clinical lineages. Population structure based on MLST Analysis of 1,125 C. jejuni genomes identified 290 unique sequence types (STs), reflecting substantial genetic diversity among C. jejuni genomes (Table S3). Sequence type distribution showed a predominance of ST-50 (n = 71), followed by ST-21 and ST-677 (n = 43 each), ST-48 and ST-51 (n = 34 each), ST-2993 (n = 33), and ST-5 (n = 24). Additional well-represented STs included ST-464 and ST-45 (n = 23 each), as well as ST-354, ST-19, and ST-2274 (n = 22 each). More than 150 STs were detected as singletons. This distribution underscores the coexistence of dominant clonal lineages with extensive rare diversity within C. jejuni populations. Of the 1,125 isolates analyzed, 1,029 were from human origin, and 96 were derived from chickens, revealing distinct host-associated ST distributions (Fig. 7a). Among chicken isolates, ST-48 (14.6%), ST-50 (10.4%), ST-51 (10.4%), and ST-2274 (10.4%) were the most prevalent lineages, collectively representing a substantial proportion of the population. In contrast, human isolates exhibited a broader distribution across multiple STs, with ST-50 (5.9%), ST-21 (4.2%), ST-677 (4.1%), and ST-2993 (3.2%) among the most frequent. Several STs, including ST-50, ST-48, ST-2274, and ST-51, were shared between hosts but showed marked differences in relative abundance, whereas ST-21, ST-2993, ST-45, ST-19, and ST-257 were exclusively detected in human-derived isolates, and ST-10,663, ST-6676, ST-10,661, ST-131, and ST-5864 were primarily associated with chickens. The statistical analysis revealed a significant association between sequence-type distribution and host source (χ2 = 16.87, p = 0.0098). Post hoc examination indicated differential enrichment of major lineages between hosts, with ST-48, ST-2274, and S-T51 more frequently associated with chicken isolates, whereas ST-50 was relatively more prevalent among human-derived isolates. These distribution patterns suggest host-associated structuring of major C. jejuni lineages. Distribution of major sequence types (STs) and clonal complexes (CCs) in C. jejuni genomes. (a) Major sequence types detected in human and chicken isolates from 1,125 C. jejuni genomes. (b) Overall distribution of the thirty clonal complexes identified across all 1,125 genomes. (c) Distribution of clonal complexes among 1,029 human isolates. (d) Distribution of clonal complexes in 96 chicken isolates. Analysis of 1,125 C. jejuni genomes revealed a diverse distribution of clonal complexes (CCs) with varying prevalence and sequence type diversity. In total, 30 CCs were identified, encompassing 218 sequence types (STs) across human and chicken-derived isolates. The ST-21 complex was the most dominant, comprising 38 STs and 221 isolates (19.6%), followed by the unassigned group (72 STs and 175 isolates, 15.6%) and the ST-353 complex (40 STs with 113 isolates, 10.0%). Other prominent complexes included ST-48 (10 STs with 61 isolates, 5.4%), ST-677 (2 STs with 55 isolates, 4.9%), ST-45 (8STs with 50 isolates, 4.4%), and ST-354 (16STs with 50 isolates, 4.4%) (Fig. 7b). Less frequent complexes, such as ST-49 (12 isolates, 1.1%), ST-508 (6 isolates, 0.5%), ST-41, ST-573, and ST-1034 (5 isolates each, 0.4%), ST-446 (3 isolates, 0.3%), and ST-179, ST-283, ST-433, and ST-581 (1 isolate each, 0.1%), further underscore the extensive CC diversity observed. The ST-21 clonal complex is widely recognized for its high pathogenic potential and frequent association with human campylobacteriosis outbreaks, a feature attributed to its extensive genetic diversity and ability to colonize multiple hosts [50]. Similarly, the ST-45 complex, prevalent in both human and poultry sources, has been repeatedly implicated in gastroenteritis outbreaks and is associated with an increased propensity for severe clinical disease [61]. Host-stratified analysis revealed distinct CC distributions among human and chicken isolates. Human-derived isolates were dominated by the ST-21, ST-353, and unassigned complexes. whereas chicken-derived isolates showed enrichment of ST-48, ST-21, ST-574, and unassigned lineages. Notably, ST-677 was predominantly associated with human isolates, while ST-48 was more frequent in chickens, further supporting host-associated lineage differentiation. The higher proportion of unassigned lineages in chicken isolates suggests greater genetic heterogeneity or under-characterized diversity in poultry-associated populations. Overall, these findings demonstrate clear host-associated differences in ST and CC distribution, indicating structured epidemiological separation between human and poultry reservoirs (Fig. 7c-d; Table S4). Distribution of transposons, replicons, and integrons in C. jejuni Comparative mobilome profiling of C. jejuni isolates from human (n = 1,029) and chicken (n = 96) sources revealed a rich repertoire of transposon abundance and diversity. A total of 57 unique transposons were identified (Fig. 8a and b). Both human- and chicken-derived isolates carried a broader transposon repertoire, with Tn1721 (1,115 copies, 99.11% genome), Tn1722 (1,112 copies, 98.84% genome), and Tn6286 (1,111 copies, 98.76% genome) being the most abundant elements, predominantly associated with antimicrobial resistance and stress adaptation [62]. Additional high-copy-number transposons included Tn6291 (687 copies, 61.07% genome), Tn6107 (489 copies, 43.47% genome), Tn6176 (502 copies, 44.62% genome), Tn6084 (485 copies, 43.11% genome) and Tn6227 (484 copies, 43.02% genome), underscoring the extensive mobilome content in human and chicken isolates and contributing to enhanced genomic plasticity and the dissemination of resistance determinants. A broad spectrum of less frequent but diverse elements, such as Tn6215, Tn6003, Tn5405, Tn6194-like, Tn6247, and Tn2010, was also identified, suggesting ongoing horizontal gene transfer at lower frequencies (Table S5). Of these 57 transposons, 10 were detected only in human-derived isolates. Although the prevalence of these nine transposons was low and classified as rare, one (Tn6177) was found with 48 copies and 4.27% of genomes marked as a host-specific mobile genetic element (Fig. 8b). Of these identified transposons, 19 were categorized as high copy numbers because they occurred three or more times per genome despite their low prevalence. At the same time, most carried 1–2 copies per genome. The transposons Tn6227, Tn6215, and Tn6003, classified as dominant, with prevalence rates of 43.02%, 5.87%, and 6.31%, respectively, had high copy numbers of 14, 13, and 8 per genome, respectively (Fig. 8c). Bar graph and box plot showing the prevalence and copy number variation of transposons in C. jejuni genomes (a) Dominant transposons detected in ≥ 5% of analyzed genomes (b) Rare transposons detected in ≤ 5% of genomes, including 10 specific to human-derived isolates (c) Copy number variation across 57 identified transposons. In addition to transposons, two plasmids were detected: a repUS2 plasmid in a single human-derived C. jejuni genome and a Col (BS512) plasmid in one in-house chicken isolate (6 H). The Col (BS512) (~ 2.1 kb, FIIA replicon) was identical to Shigella boydii pBS512 and lacked resistance genes, while repUS2 was rare and poorly characterized [63]. Notably, no integrons were detected in any isolate, despite the presence of multiple mobile genetic elements (Table S5). Discussion This study provides a comprehensive assessment of AMR, potential virulence, and genomic adaptability in C. jejuni as gleaned from 1,125 high-quality C. jejuni genomes from human and chicken hosts across multiple geographic regions worldwide. By integrating antimicrobial susceptibility testing, whole-genome sequencing, resistome and virulome profiling, and comparative genomics, we delineated global and host-associated patterns of resistance determinants, virulence factors, and core-genome architecture in C. jejuni. Genomes spanning 28 countries and 50 distinct sample types from two major hosts enabled robust evaluation of evolutionary dynamics, host adaptation, and zoonotic potential, offering new insights into the epidemiology of this clinically and agriculturally important pathogen. However, the dataset was found to be skewed due to the high representation of isolates and genomes from the United Kingdom and human hosts; this should be carefully considered when making any sweeping interpretations. Phylogenetic analysis revealed three major clades, with human isolates distributed across all clades, whereas chicken isolates, including in-house isolates, as described, were predominantly restricted to clade 1. This host-associated clustering suggests lineage-specific adaptation in chickens, whereas the distribution of human isolates across clades reflects multiple sources of infection and complex transmission dynamics [64, 65]. The limited genetic diversity of chicken-associated lineages may indicate clonal expansion in commercial production systems [31], which employ uniform feed and antimicrobials, whereas human infections likely originate from diverse environmental and zoonotic sources. Pangenome analysis further demonstrated the genomic plasticity of C. jejuni, with 4,489 orthologous gene clusters and 1,360 core genes present in ≥ 99% of isolates. The pangenome exhibits a weakly open structure approaching saturation. The Heaps’ law exponent (β = 0.114) indicates that novel genes continue to accumulate as additional genomes are sequenced, although at a relatively low rate compared with highly diverse bacterial species. Consistent with this, the number of newly identified genes per genome declined from 2.11 during early sampling to 0.46 after analyzing 1,125 genomes, suggesting that most of the species’ gene diversity has already been captured. Furthermore, the core genome stabilized at approximately 1,360 genes, indicating a relatively conserved set of essential genes shared by most strains [66, 67]. Rarefaction-based analyses similarly demonstrate that core genome size approaches a plateau as sampling increases, supporting convergence [68]. This stability reflects a conserved set of genes, many of which are essential and shared across nearly all strains. Together, these findings indicate moderate genomic plasticity alongside a stable core genome, reflecting evolutionary constraints on essential cellular functions while permitting limited variation in accessory genes. Core genes predominantly encode essential cellular functions, including translation, ribosomal structure, energy metabolism, cell wall biogenesis, and inorganic ion transport, as well as multidrug efflux pumps and metallo-β-lactamases, highlighting the role of the core genome in both bacterial fitness and intrinsic resistance [51]. In contrast, accessory genes, including 459 C. jejuni-specific genes, were enriched for functions related to replication, recombination and repair, defense mechanisms, and transcription, reflecting their contribution to host adaptation, virulence potential, and niche specialization. The substantial proportion of uncharacterized genes in both the core and accessory genomes further underscores the need for functional studies to elucidate the mechanisms underlying C. jejuni pathogenicity and the evolution of resistance [69]. The widespread multidrug resistance (MDR) observed in both in-house and global C. jejuni isolates underscores a significant and persistent public health concern. Resistance to fluoroquinolones, macrolides, tetracyclines, aminoglycosides, and β-lactams was widespread, with particularly high prevalence of tetracycline resistance (tetO) and OXA-type β-lactamases among chicken-associated isolates. Detection of the class A TEM-116 β-lactamase in an in-house isolate (5H) suggests the emergence of rare or geographically restricted resistance determinants, possibly due to sustained antimicrobial selection pressure in poultry production systems [70, 71]. Multidrug efflux systems, particularly the cmeABC operon and its regulator cmeR, were nearly ubiquitous, reflecting their central role in intrinsic and acquired resistance mechanisms [51, 55]. The differential prevalence of AMR genes between poultry and human isolates, the significantly higher prevalence of tetO in poultry-derived isolates, is consistent with the well-documented impact of agricultural antimicrobial use in driving selection of resistant C. jejuni populations [72, 73], whereas differences observed for OXA-type β-lactamases (e.g., OXA-450) were not statistically significant, suggesting more heterogeneous distribution patterns. Notably, although all in-house isolates exhibited an ESBL phenotype by the Double Disc Synergy Test (DDST), only one isolate harbored a recognized ESBL-associated gene (TEM-116), while others carried OXA-450 or lacked identifiable ESBL genes. OXA-type β-lactamases, including OXA-450, are generally considered narrow-spectrum enzymes, and their role as ESBLs in C. jejuni remains unclear. The observed phenotype in isolates lacking known ESBL genes may therefore reflect the combined effects of intrinsic resistance mechanisms, including the cmeABC efflux system, or the presence of uncharacterized β-lactamase variants not detected by current databases. Additionally, because DDST is not standardized for Campylobacter spp., false-positive ESBL results cannot be ruled out and should be interpreted with caution. Point mutation analysis further corroborated the observed phenotypic resistance patterns. The gyrA p.T86I substitution, conferring fluoroquinolone resistance, was detected in ~ 60% of isolates across both hosts, consistent with its recognition as a stable, high-frequency resistance marker in C. jejuni populations worldwide [74]. In contrast, additional QRDR mutations were confined mainly to human isolates, suggesting selective pressures from clinical fluoroquinolone use. Macrolide resistance-associated 23S rRNA mutations were comparatively infrequent (~ 6.5%) and exhibited host-specific distributions, with only a single poultry isolate harboring the 23S r2075A > G mutation, highlighting differential antimicrobial exposure and selection between human and animal populations. Streptomycin resistance mediated by rpsL p.K43R was rare, reflecting the limited use of aminoglycosides in both clinical and agricultural settings [75]. Collectively, these findings demonstrate that resistance in C. jejuni is driven by a combination of acquired resistance and chromosomal point mutations under host-specific selective pressures. Virulome analysis revealed a highly conserved repertoire of virulence factors across human and poultry isolates. Core virulence determinants, including genes for flagellar assembly and motility, cadF and pebA adhesion factors, capsule biosynthesis operons (kps), and lipooligosaccharide (LOS) biosynthesis genes, were present in > 88–100% of genomes, with poultry isolates showing slightly higher uniformity. Cytolethal distending toxin genes (cdtA, cdtB, cdtC) were nearly universal, suggesting widespread genotoxic potential. Glycosylation-associated genes, essential for flagellin modification and immune evasion, were also highly conserved, although certain maf and pse genes exhibited lineage-specific variability. Accessory virulence elements, including flaA/flaB flagellin genes and type IV secretion system components, were less frequent, suggesting restricted horizontal gene transfer or niche-specific adaptations [76]. The co-occurrence of multidrug resistance and a conserved virulence repertoire underscore the dual threat posed by C. jejuni, with strains capable of both causing disease and evading treatment. Chicken isolates harbouring both AMR determinants and conserved virulence factors reinforce the role of poultry as a major reservoir for human infection and highlight the potential for foodborne dissemination of high-risk lineages [4, 77]. These findings are particularly pertinent in regions such as India, where antibiotic use in poultry remains substantial and monitoring of zoonotic pathogens is limited. Analysis of plasmids, integrons, and transposons provides insight into the mechanisms driving the dissemination of resistance in C. jejuni. Although traditional replicons (plasmids) and integrons were largely absent, suggesting a limited role in horizontal gene transfer (HGT), numerous transposons were detected, indicating a significant, albeit distinct, mode of HGT by serving as vectors for resistance islands and toxin-antitoxin systems [78]. Comparative mobilome profiling revealed that human-derived isolates possess a more diverse and abundant transposon repertoire than chicken-derived isolates, indicating greater genomic plasticity and potential for HGT in human-associated lineages [79]. High-copy-number transposons, including Tn6107, Tn1721, Tn1722, Tn6286, and Tn2010, appear to play a central role in shaping the mobilome of human isolates [80]. Conversely, chicken isolates exhibited a narrower mobilome, with fewer transposons overall, yet several elements were present in substantial copy numbers [81]. The absence of integrons and the limited plasmid carriage across hosts highlight the primary role of transposons in genomic variability and adaptation in C. jejuni populations. The observed ST and CC distributions underscore both the extensive genetic diversity of C. jejuni populations and clear host-associated trends that may shape its epidemiology. The predominance of ST-21 and ST-353 complexes in human isolates aligns with their established roles in human campylobacteriosis, reflecting broad host range and high virulence potential [82, 83]. Conversely, the enrichment of ST-48 and unassigned lineages among chicken isolates suggests the presence of host-adapted or under-characterized strains circulating within poultry reservoirs. Shared STs such as ST-50 and ST-48 across both hosts reinforce poultry as a major source of human infection. The high proportion of singleton STs and unassigned lineages suggests ongoing diversification and the emergence of genetically novel strains. Differential prevalence of CCs, particularly the dominance of ST-677 in human isolates and of ST-48 in chickens, points to potential host-specific evolutionary pressures. These findings provide important insights into C. jejuni population structure, emphasizing the need for integrated genomic surveillance to track dominant lineages, understand transmission pathways, and support targeted intervention strategies to mitigate the burden of campylobacteriosis. In conclusion, our study highlights the intricate interplay among microbial evolution, the emergence of AMR, and human health. Through a high-resolution analysis of 1,125 C. jejuni genomes from human and chicken sources, we reveal core-genome conservation, host-specific clustering, widespread AMR, and extensive virulence repertoires, underscoring the pathogen’s evolutionary success and public health significance. The accumulation of resistance and virulence factors in chicken-associated isolates reflects systemic gaps in poultry production, including excessive antibiotic use, inadequate biosecurity, and insufficient farm-level monitoring. Such practices facilitate the emergence and dissemination of AMR and increase the risk of pathogen transmission along the food chain, posing threats to both animal and human health. Our findings underscore the urgent need for integrated One Health surveillance, prudent antimicrobial stewardship in clinical and agricultural settings, and targeted interventions to curb the dissemination of MDR C. jejuni. These strategies are essential in LMICs, where poultry-associated AMR reservoirs remain poorly understood despite their significant impact on food safety and public health. Implementing on-farm genomic surveillance, enforcing prudent antibiotic use, and improving biosecurity and hygiene practices are critical to mitigating the amplification of resistance. Ultimately, addressing AMR and emerging pathogen threats requires a holistic, cross-sectoral approach rooted in the One Health paradigm. While this study provides a comprehensive genomic analysis of 1,125 C. jejuni isolates, several avenues for further exploration remain. Although draft and high-quality assemblies provide robust insights, complete long-read sequencing could more accurately resolve mobile genetic elements and capture rare or hard-to-sequence strains. The numerous uncharacterized genes identified here warrant functional validation, and expanding the dataset to include more geographically and environmentally diverse isolates would strengthen generalizability. In addition, the current dataset is unevenly distributed, with overrepresentation of the isolates and genomes from the United Kingdom and human-derived isolates, which may influence phylogenetic reconstruction, sequence type distribution, and antimicrobial resistance estimates. Future research should integrate long-read genome sequencing, experimental verification of key resistance and virulence determinants, and longitudinal host- and environment-specific studies to monitor the emergence of novel resistance genes and hypervirulent clones. Conclusion The findings reported herein provide comprehensive insights into the evolution, transmission dynamics, host adaptation, antimicrobial resistance, and pathogenic potential of C. jejuni. Poultry serves as a critical reservoir driving the emergence and dissemination of high-risk, pathogenic, and drug-resistant lineages, emphasizing the importance of monitoring and controlling AMR in livestock to protect public health. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5. Acknowledgements We sincerely thank the University of Sharjah for its support during the genome analysis part of this study. We would like to thank the University of Hyderabad and members of the Pathogen Biology Laboratory for the in-house resources and for discussions, respectively. Author contributions S.Q. and N.A. conceived and conceptualized the study. S.Q. developed the methodology and carried out the investigation, while data curation was performed by S.Q. and N.A. Formal analysis was conducted by S.Q. and N.A., and M. H. provided resources. N.A. and S.Q. drafted the original manuscript. M.H., R.A., and G.K. contributed to the review and editing of the manuscript. All authors reviewed and approved the final version of the manuscript. Funding This research received no external funding. Data availability All genome assemblies generated in this study have been deposited in NCBI. Genome Accession numbers for individual isolates are provided in Table 2. Ethics declarations Ethics approval and consent to participate Not applicable. Competing interests NA is the Editor-in-Chief of Gut Pathogens, but he has not, overseen the peer-review or decision-making process for this article. All other authors declare that they have no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Citations Supplementary Materials Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5. Data Availability Statement All genome assemblies generated in this study have been deposited in NCBI. Genome Accession numbers for individual isolates are provided in Table 2.